Clinical trials
Completed Non-alcoholic Fatty Liver Disease trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2014 | 2 |
| 2016 | 5 |
| 2017 | 3 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 5 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Novo Nordisk A/S | 3 |
| AstraZeneca | 2 |
| Fundació Eurecat | 2 |
| Biosearch S.A. | 1 |
| Cellaion SA | 1 |
| Conatus Pharmaceuticals Inc. | 1 |
| Eli Lilly and Company | 1 |
| Fundacion SEIMC-GESIDA | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 33 |
| Liver Diseases | 6 |
| Fibrosis | 5 |
| Fatty Liver | 4 |
| Liver Cirrhosis | 4 |
| Metabolic Syndrome | 3 |
| Obesity | 3 |
| Digestive System Diseases | 2 |
| Obesity, Abdominal | 2 |
| Cardiovascular Diseases | 1 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.